| Courageous' treatment for stable coronary disease | What is the optimal medical therapy? | Boden (Buffalo, US) |
| Courageous' treatment for stable coronary disease | Who should receive percutaneous intervention? | Shelton M (Springfield, US) |
| Courageous' treatment for stable coronary disease | Persistent angina / ischaemia: what to do? | Danchin N (Paris, FR) |
| Hot Line I | The BEAUTIFUL study: efficacy of ivabradine in reduction of cardiovascular events among patients with stable coronary artery disease and left ventricular dysfunction - Discussant. | Smith S (Chapel Hill, US) |
| Moving from cure to palliation | Palliative care in refractory angina. | Wright C (London, GB) |
| Clinical Trial Update II | Prognostic value of resting heart in patients with stable coronary artery disease, from the randomised, double-blind, placebo-controlled, multicentre EUROPA trial. - Discussant. | Danchin N (Paris, FR) |
| Antithrombotic and antiplatelet treatment in coronary artery disease: 2008 | Chronic coronary artery disease. | D L Bhatt (Newton, US) |